Profile data is unavailable for this security.
About the company
Can Fite Biofarma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. It's technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.
- Revenue in ILS (TTM)2.49m
- Net income in ILS-27.54m
- Incorporated1994
- Employees5.00
- LocationCan-Fite Biopharma Ltd26 Ben Gurion StreetRAMAT GAN 5257346IsraelISR
- Phone+972 39241114
- Fax+972 39249378
- Websitehttps://www.canfite.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BLIS Technologies Ltd | 25.21m | 1.41m | 53.17m | 10.00 | 32.20 | 2.12 | 20.70 | 2.11 | 0.0006 | 0.0006 | 0.0091 | 0.009 | 0.8955 | -- | 8.41 | -- | 5.02 | -2.45 | 5.64 | -2.90 | -- | -- | 5.60 | -2.40 | 8.30 | 23.45 | 0.0328 | -- | 12.61 | 6.52 | 147.85 | 11.14 | 34.35 | -- |
| Can Fite Biopharma Ltd | 2.49m | -27.54m | 55.10m | 5.00 | -- | 4.87 | -- | 22.11 | -0.0176 | -0.0176 | 0.0017 | 0.0055 | 0.0787 | -- | -- | 498,409.10 | -86.95 | -102.29 | -115.77 | -131.07 | -- | -- | -1,105.10 | -1,105.36 | -- | -- | 0.00 | -- | -8.27 | -27.92 | 24.96 | -- | -42.92 | -- |
| Nyrada Inc | 8.21m | -3.36m | 55.65m | -- | -- | 3.97 | -- | 6.78 | -0.0081 | -0.0081 | 0.0209 | 0.0277 | 0.6147 | -- | -- | -- | -25.13 | -53.28 | -29.75 | -62.52 | -- | -- | -40.89 | -236.15 | -- | -- | 0.00 | -- | 115.55 | 46.42 | 82.12 | -- | -- | -- |
| SMAIO SA | 19.34m | -7.06m | 55.80m | 43.00 | -- | 1.76 | -- | 2.88 | -0.3383 | -0.3383 | 0.929 | 1.54 | 0.3738 | 0.3816 | 9.41 | 132,756.80 | -13.65 | -7.87 | -15.68 | -18.43 | 88.45 | 96.04 | -36.52 | -22.48 | 4.25 | -- | 0.236 | -- | 212.18 | 114.99 | -62.80 | -- | -- | -- |
| Extrawell Pharmaceutical Holdings Ltd | 28.40m | -78.31m | 56.28m | 159.00 | -- | 0.1052 | -- | 1.98 | -0.0682 | -0.0682 | 0.0247 | 0.4657 | 0.0433 | 5.90 | 11.81 | 371,685.50 | -11.83 | 1.01 | -12.32 | 1.06 | 48.70 | 50.54 | -273.51 | 18.00 | 3.31 | -0.0753 | 0.0977 | 0.00 | -18.57 | -7.91 | -226.06 | -- | -3.20 | -- |
| IX Biopharma Ltd | 16.55m | -29.99m | 56.44m | 56.00 | -- | 4.07 | -- | 3.41 | -0.014 | -0.014 | 0.0078 | 0.0057 | 0.3013 | 4.20 | 1.99 | -- | -54.58 | -39.79 | -86.37 | -52.71 | 17.59 | 50.67 | -181.14 | -150.87 | 0.7053 | -2.42 | 0.5451 | -- | 0.778 | 54.77 | -12.26 | -- | -29.94 | -- |
| Lasa Supergenerics Ltd | 46.32m | -8.64m | 57.12m | 77.00 | -- | -- | -- | 1.23 | -3.92 | -3.92 | 20.94 | -- | -- | -- | -- | 13,586,300.00 | -- | -3.86 | -- | -5.34 | 26.41 | 32.53 | -18.65 | -5.30 | -- | -4.49 | -- | -- | -19.47 | -9.26 | 43.73 | -- | -- | -- |
| Gelteq Ltd | 0.00 | -5.71m | 57.18m | -- | -- | 1.09 | -- | -- | -0.1597 | -0.1597 | 0.00 | 1.49 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.38 | -32.41 | 0.0605 | -- | -- | -- | -72.77 | -- | -- | -- |
| Bright Green Corp | 0.00 | -37.08m | 57.31m | 5.00 | -- | 1.54 | -- | -- | -0.0538 | -0.0538 | 0.00 | 0.0519 | 0.00 | -- | -- | 0.00 | -47.48 | -- | -72.55 | -- | -- | -- | -- | -- | -- | -- | 0.0494 | -- | -- | -- | 52.54 | -- | -- | -- |
| Phapros Tbk PT | 190.21m | -11.00m | 57.86m | 1.38k | -- | 0.3573 | 259.50 | 0.3042 | -55.54 | -55.54 | 960.00 | 817.32 | 0.4587 | 1.44 | 1.51 | 547,082,300.00 | -2.69 | 2.07 | -4.42 | 4.04 | 48.90 | 51.79 | -5.86 | 3.68 | 1.10 | 0.0247 | 0.5173 | -- | -13.21 | -0.1734 | -78.77 | -46.21 | -24.81 | -- |
Data as of Nov 14 2024. Currency figures normalised to Can-Fite Biopharma Ltd's reporting currency: Israeli Shekel ILS
